Lorazepam and Advicor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Advicor (lovastatin; niacin). Common drug interactions include blood creatinine increased among females and arrhythmia among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Advicor. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Advicor?

Advicor has active ingredients of lovastatin; niacin. It is often used in high blood cholesterol. eHealthMe is studying from 1,153 Advicor users. Check the latest studies of Advicor.



On Jul, 26, 2026

19 people who take Lorazepam and Advicor together, and have interactions are studied.

Lorazepam and Advicor drug interactions.

What are the common drug interactions of Lorazepam and Advicor, by gender? *:

female:

  1. Blood creatinine increased
  2. Blood glucose increased
  3. Dehydration (dryness resulting from the removal of water)
  4. Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection)
  5. Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
  6. Hepatic steatosis (fatty liver disease)
  7. Hypertriglyceridaemia (excess of triglycerides in the blood)
  8. Renal disorder (kidney disease)
  9. Type 2 diabetes mellitus
  10. Ulcer

male:

  1. Arrhythmia (irregular heartbeat)
  2. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  3. Hepatic failure (liver failure)
  4. Liver disorder (liver diseases)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Renal failure acute (rapid kidney dysfunction)
  7. Septic shock (shock due to blood infection)
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Pneumonia

What are the common drug interactions of Lorazepam and Advicor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Carpal tunnel decompression
  2. Drug effect decreased
  3. Nerve compression
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  5. Pain
  6. Surgery
  7. T-cell lymphoma (a blood cell cancer)

50-59:

  1. Arrhythmia (irregular heartbeat)
  2. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  3. Cardiac failure congestive
  4. Cardiac output decreased
  5. Cardiogenic shock (inadequate circulation of blood)
  6. Cerebellar ischaemia (lack of blood supply to cerebeller)
  7. Encephalopathy (functioning of the brain is affected by some agent or condition)
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Haematoma (collection of blood outside the blood vessels)
  10. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)

60+:

  1. Depression
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Renal impairment (severely reduced kidney function)
  4. Renal injury (kidney injury)
  5. Abdominal pain
  6. Back pain
  7. Blood creatinine increased
  8. Blood glucose increased
  9. Blood pressure systolic increased
  10. Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 1 person, 5.26%
  2. Metastatic Carcinoid Tumor: 1 person, 5.26%
  3. High Blood Pressure: 1 person, 5.26%
  4. Erection Problems: 1 person, 5.26%
  5. Diabetes: 1 person, 5.26%
  6. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Advicor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lorazepam and Advicor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Advicor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lorazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Advicor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and lovastatin; niacin (the active ingredients of Lorazepam and Advicor, respectively), and Lorazepam and Advicor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: